US Stem Cell Inc (USRM)

[Zues]

Vey nice post as usual.

"We will need a catalyst" > Q2 should do that in the short term.

"...we can determine that this play is not over yet" > Yes.

"...will serve as a good plan B should RMAT not come through." I see it the other way round. Texas as plan A, RMAT an afterthought as is buyout.

I see Texas as the big ticket because it will allow USRM to conduct business without the threat of the FDA interfering (the scope of their practice will be dependent upon provisions within the legislation +/- MyoCell). Other states will most likely follow Texas but it will take many months of special interest involvement to get it passed into law.

If USRM does not provide convincing evidence that they are actually opening a clinic in Texas before year end I will most likely begin to reduce my position after holding since 1/01/17 (other people will happily snatch the shares).

If RMAT status is granted that changes everything, but I remain skeptical because there are no guidelines...yet (something we should have been cautioned of back in January).